However, among patients with mild liver disease (F0-2), the proportion of fibrosis improvement was significantly higher in those with the TLL-1 rs17047200 AA genotype compared to those with a non-AA genotype at (33.3% vs. 0%, p = 0.005) (Fig. 2). Here, TLL1 is linked to liver disorder.